MIM
CGEM icon

MetLife Investment Management’s Cullinan Oncology CGEM Stock Holding History

MetLife Investment Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$438K Hold
30,816
– – ﹤0.01% 1821
2025
Q4 		$319K Buy
30,816
+7,571
+33% +$68.3K ﹤0.01% 2032
2025
Q3 		$138K Sell
23,245
-8,209
-26% -$60.1K ﹤0.01% 2503
2025
Q2 		$237K Hold
31,454
– – ﹤0.01% 2103
2025
Q1 		$238K Sell
31,454
-604
-2% -$5.8K ﹤0.01% 2109
2024
Q4 		$390K Buy
32,058
+2,217
+7% +$31.9K ﹤0.01% 1929
2024
Q3 		$500K Buy
29,841
+7,115
+31% +$126K ﹤0.01% 1784
2024
Q2 		$396K Buy
22,726
+9,389
+70% +$200K ﹤0.01% 1855
2024
Q1 		$227K Hold
13,337
– – ﹤0.01% 2127
2023
Q4 		$136K Hold
13,337
– – ﹤0.01% 2450
2023
Q3 		$121K Hold
13,337
– – ﹤0.01% 2484
2023
Q2 		$144K Sell
13,337
-3,088
-19% -$32.8K ﹤0.01% 2472
2023
Q1 		$168K Hold
16,425
– – ﹤0.01% 2324
2022
Q4 		$173K Sell
16,425
-3,464
-17% -$42.1K ﹤0.01% 2336
2022
Q3 		$255K Buy
19,889
+4,491
+29% +$60.5K ﹤0.01% 2130
2022
Q2 		$197K Hold
15,398
– – ﹤0.01% 2324
2022
Q1 		$161K Buy
15,398
+5,590
+57% +$75.5K ﹤0.01% 2479
2021
Q4 		$151K Hold
9,808
– – ﹤0.01% 2228
2021
Q3 		$221K Buy
9,808
+3,710
+61% +$99.2K ﹤0.01% 2025
2021
Q2 		$157K Hold
6,098
– – ﹤0.01% 2303
2021
Q1 		$254K Buy
+6,098
New +$248K ﹤0.01% 1919

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MetLife Investment Management's CGEM Position: Q1 2026 in Review

MetLife Investment Management held its Cullinan Oncology (CGEM) position steady in Q1 2026 at 30,816 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

MetLife Investment Management first reported a position in CGEM in Q1 2021 and has held it in 21 quarters since. The position peaked at $500K in Q3 2024. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • MetLife Investment Management held 30,816 shares of Cullinan Oncology worth $438K as of Q1 2026.
  • MetLife Investment Management left its Cullinan Oncology share count unchanged in Q1 2026.
  • Cullinan Oncology made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1821 holding.
  • MetLife Investment Management first reported a position in Cullinan Oncology in Q1 2021 and has held it in 21 quarters since.
  • MetLife Investment Management's Cullinan Oncology position peaked at $500K in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.